Yahoo
NSE - Delayed Quote INR

Archean Chemical Industries Limited (ACI.NS)

431.05 +6.35 (+1.50%)
At close: 3:30:01 PM GMT+5:30
Chart Range Bar
Loading chart for ACI.NS
  • Previous Close 424.70
  • Open 420.10
  • Bid --
  • Ask --
  • Day's Range 420.10 - 433.30
  • 52 Week Range 413.80 - 639.90
  • Volume 89,008
  • Avg. Volume 372,562
  • Market Cap (intraday) 53.219B
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 53.08
  • EPS (TTM) 8.12
  • Earnings Date --
  • Forward Dividend & Yield 2.50 (0.60%)
  • 1y Target Est 564.67
  • Moby Rating Neutral

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.

www.archeanchemicals.com

257

Full Time Employees

March 31

Fiscal Year Ends

Chemicals

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ACI.NS
22.27%
S&P BSE SENSEX (^BSESN)
4.95%

1-Year Return

ACI.NS
31.75%
S&P BSE SENSEX (^BSESN)
2.66%

3-Year Return

ACI.NS
16.51%
S&P BSE SENSEX (^BSESN)
24.66%

5-Year Return

ACI.NS
4.21%
S&P BSE SENSEX (^BSESN)
33.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 2.97B
Earnings 320.62M
Profit Margin 10.78%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
1B
2B
3B
6.0%
8.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

545.00
564.67 Average
431.05 Current
620.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.50%

  • Return on Assets (ttm)

    3.38%

  • Return on Equity (ttm)

    5.07%

  • Revenue (ttm)

    11.8B

  • Net Income Avi to Common (ttm)

    1B

  • Diluted EPS (ttm)

    8.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    482.13M

  • Total Debt/Equity (mrq)

    28.12%

  • Levered Free Cash Flow (ttm)

    -3.66B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: